Paper16557282
Protein-tyrosine phosphatases and cancer.
Ostman A and 2 others. Nat Rev Cancer, 2006. Cited by 548 papers, by iCite.
Cite this record
ConductScience Library. Protein-tyrosine phosphatases and cancer. Papers, record 16557282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16557282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Protein Tyrosine Phosphatases | Major topic |
| Animals | |
| ErbB Receptors | |
| Humans | |
| Phosphorylation | |
| Tyrosine |
Source PubMed
Cited by329
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 548 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42451698 | Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models. | Molecules | 2026 | https://conductscience.org/library/papers/42451698 | PubMed |
| 42423920 | Multicomponent reactions for protein tyrosine phosphatase inhibitors. | Mol Divers | 2026 | https://conductscience.org/library/papers/42423920 | PubMed |
| 42212130 | Single-cell and spatial transcriptomic profiling reveals the expression characteristics of PTPRR in epithelial cells and its potential implications in pancreatic cancer metastasis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42212130 | PubMed |
| 42072080 | Hepatic ACSL4 Loss Boosts Endogenous Gamma-Glutamylcysteine to Alleviate Alcoholic Liver Disease. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072080 | PubMed |
| 41808249 | Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41808249 | PubMed |
| 41718985 | Golgi Retention and Oncogenic Signaling of KIT Tyrosine Kinase in Gastrointestinal Stromal Tumor. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/41718985 | PubMed |
| 41559020 | The R451 site is critical for PTPN18 to exert tumor suppressive effects in breast cancer through the negative regulatory interacting protein fibrillarin. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41559020 | PubMed |
| 41557758 | Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC. | Sci Signal | 2026 | https://conductscience.org/library/papers/41557758 | PubMed |
| 41486293 | Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer. | Cell Res | 2026 | https://conductscience.org/library/papers/41486293 | PubMed |
| 41327349 | Genome-wide association study of lung function decline using elastic-net regression: a prospective analysis in Korean cohort. | Hum Genomics | 2025 | https://conductscience.org/library/papers/41327349 | PubMed |
| 41154495 | The Redox Paradox: Cancer's Double-Edged Sword for Malignancy and Therapy. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41154495 | PubMed |
| 40864347 | Tissue-specific profiling of human protein phosphatases identifies G6PC1 as a liver cancer-selective biomarker. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40864347 | PubMed |
| 40355891 | Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology. | J Transl Med | 2025 | https://conductscience.org/library/papers/40355891 | PubMed |
| 40341216 | PRL-3: unveiling a new horizon in cancer therapy. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40341216 | PubMed |
| 40260019 | SHP099-containing multi-targeting hydrogel promotes rapid skin reconstruction through modulating a variety of cells. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40260019 | PubMed |
| 40140631 | Malignant JAK-signaling: at the interface of inflammation and malignant transformation. | Leukemia | 2025 | https://conductscience.org/library/papers/40140631 | PubMed |
| 40073865 | Proteome-wide assessment of differential missense variant clustering in neurodevelopmental disorders and cancer. | Cell Genom | 2025 | https://conductscience.org/library/papers/40073865 | PubMed |
| 40016288 | PTPRO represses breast cancer lung metastasis by inhibiting the JAK2-YAP axis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40016288 | PubMed |
| 39906260 | Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture. | JBMR Plus | 2025 | https://conductscience.org/library/papers/39906260 | PubMed |
| 39794316 | Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/39794316 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTPN11 | 5781 | PubTator's text mining | https://conductscience.org/library/genes/5781 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16557282
GET https://conductscience.org/api/papers/v1/16557282/cited_by?page=2